Singapore, Aug. 27 -- Dubai Investments, a leading investment company listed on the Dubai Financial Market in the UAE, through its wholly owned subsidiary Globalpharma - UAE's leading pharmaceutical manufacturer, has signed Memorandum of Understanding (MoU) with Angola's Ministry of Health to establish a pharmaceutical manufacturing facility in Dubai Investments Park (DIP), Angola.

The MoU reflects the strengthened bilateral relations highlighted during the recent UAE delegation visit to Angola, led by Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates and Ruler of Abu Dhabi, underscoring both nations' commitment to advancing collaboration and sustainable growth across key sectors.

As part of the MoU, Globalpharma...